Chess Robert
Twist Bioscience Corporation · Director
Chess Robert is listed in filings as Director at Twist Bioscience Corporation. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Twist Bioscience Corporation (TWST) and Nektar Therapeutics (NKTR). The current snapshot covers public activity from Jun 14, 2024 to Mar 19, 2026. Reported amounts are shown as $470.0K to $105.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $105k2.2k shares | SellFeb 13, 2026 | $48.26 | $92.61 | |
| $156k2.9k shares | SellFeb 7, 2025 | $53.14 | $92.61 | |
| $250k5k shares | SellJan 7, 2025 | $50.00 | $92.61 | |
| $145k2.8k shares | SellDec 5, 2024 | $51.70 | $92.61 | |
| $37k709 shares | SellDec 5, 2024 | $52.45 | $92.61 | |
| $109k2.3k shares | SellNov 11, 2024 | $46.99 | $92.61 | |
| $61k1.3k shares | SellNov 11, 2024 | $47.76 | $92.61 | |
| $23k19.5k shares | SellJun 14, 2024 | $1.20 | $68.30 |